Diseases, Conditions, Syndromes

Long-term mortality risk low after cerebral vein thrombosis

(HealthDay) -- For patients who survive a cerebral vein thrombosis (CVT), the long-term risk of mortality and recurrent venous thromboembolism (VTE) seems to be low, according to a study published in the July issue of the ...

Diseases, Conditions, Syndromes

Higher risk of VTE in CKD surgical patients on enoxaparin

(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin compared to those ...

Diseases, Conditions, Syndromes

Venous thromboembolism up in adult hospitalizations

(HealthDay) -- Every year, more than half a million hospitalized U.S. adults acquire venous thromboembolism (VTE), a growing public health concern that is often preventable, according to research published in the June 8 issue ...

Oncology & Cancer

Prophylaxis with apixaban feasible for cancer patients

(HealthDay) -- Primary venous thromboembolism prophylaxis with apixaban, an oral direct Factor Xa inhibitor, in ambulatory cancer patients undergoing first- or second-line chemotherapy for advanced or metastatic cancer, is ...

Diseases, Conditions, Syndromes

New risk score spots patients at high risk of serious blood clots

A new risk prediction tool can identify patients at high risk of serious blood clots (known as venous thromboembolism) who might need preventative treatment, says a study published in the British Medical Journal today.

page 20 from 20